Panel Discussion: Developing Flexible Platform Technologies to Enable Scale Up or Down to Enable Roll Out of mRNA Vaccines & Therapeutics to Patients Faster
Time: 2:30 pm
day: Day One
Details:
- How quickly can a small batch size be upscaled to enable rapid roll out of manufacturing for emerging and future health threats?
- Can we leverage current large scale platform technologies for smaller scale process development and manufacturing for personalised mRNA drugs?
- How can we achieve process control strategies that fit a flexible platform for improved and standardised parameters?
